Feelemyer, Jonathan http://orcid.org/0000-0001-6617-4992
Duncan, Dustin T.
Akhidenor, Naomi
Mazumdar, Medha
Irvine, Natalia M.
Scheidell, Joy D.
Brewer, Russell A.
Turpin, Rodman E.
Hucks-Ortiz, Christopher
Dyer, Typhanye V.
Cleland, Charles M.
Mayer, Kenneth H.
Khan, Maria R.
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA044037, P30 DA011041, R01 DA028766)
National Institute of Allergy and Infectious Diseases (UM1AI068619, UM1 AI068617, UM1 AI068613, P30 AI060354, UM1 AI069480, P30 AI087714, 5U01 AI069466, 3U01 AI069466-03S1, 3U01 AI069496-03S1, 3U01 AI069496-03S2, U01AI069424, P30DA027828)
National Center for Research Resources (UL1 RR025008)
National Center for Chronic Disease Prevention and Health Promotion (U48 DP006382, U48 DP005008)
Article History
Received: 12 May 2023
Revised: 15 December 2023
Accepted: 4 January 2024
First Online: 12 April 2024
Declarations
:
: This is an observational study. The Institutional Review Board at NYU Grossman School of Medicine has confirmed that no ethical approval is required.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of the results of this study.
: The authors declare no competing interests.
: The funding agencies had no role in designing the research, data analyses, and preparation of the report.